Talking about and Using Pharmacoeconomics Properly

Abstract

Managed health care has changed the way health services are provided and paid for. It is still evolving. Many pharmacists have already felt the impact of these changes. This continuing feature illuminates the many facets of managed care with special emphasis placed on how these changes may affect pharmacists working in health systems. The expertise provided by pharmacists will be needed to fulfill the potential of affordable, comprehensive, and quality health care as promised by managed care. Pharmacists must understand what is happening, why it is happening, and what is likely to happen in the future. To be an active and effective player, you must understand what is happening on the field.

Get full access to this article

View all access options for this article.

References

Luks-Golger

, Caspi

The ABC's of pharmacoeconomic research. Pharmacol Ther. 2000; 25(2): 88–90.

Arikian

Pharmacoeconomic design. Managed Healthcare. 2000; 10(2 suppl):5–7.

Heaton

Pharmacoeconomics in a managed care setting. Managed Healthcare. 2000; 10(2): 8–11.

McCloskey

W.M.

Principles of drug literature evaluation. In: Vogenberg

, ed. Introduction to Applied Pharmacoeconomics. New York: McGraw-Hill; 2001.

Voelker

A “family heirloom” turns 50. JAMA. 1998; 279: 1241–5.

Milne

R.J.

Evaluation of the pharmacoeconomic literature. Pharmacoeconomics. 1994; 6: 337–45.

Sacristan

J.A.

, Soto

, Galende

Evaluation of pharmacoeconomic studies: Utilization of a checklist. Ann Pharmacother. 1993; 27: 1126–33.

Jolicoeur

L.M.

, Jones-Grizzle

A.J.

, Boyer

J.G.

Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm. 1992; 49: 1741–7.

Garfield

How can impact factors be improved?

BMJ. 1996; 313: 411–3.